Navigation Links
Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
Date:12/3/2008

WASHINGTON, Dec. 3 /PRNewswire-USNewswire/ -- Dr. Charmaine Yoest, President & CEO of Americans United for Life released the following statement in response to news that leaders in Congress plan to make funding embryo destructive stem cell research a priority.

"Given the current state of the economy, to squander taxpayer resources on research that destroys human embryos, that shows no actual therapeutic results, and that in fact runs counter to the latest stem cell discoveries (induced pluripotent stem cells or iPSCs) is nothing more than ideologically-driven government at its very worst.

"It is mystifying why Speaker Pelosi and other leaders in Congress continue to push for funding to destroy human embryos in the face of continued success with stem cells from bone marrow, umbilical cords, and other non-embryonic sources."

About Americans United for Life

Americans United for Life (AUL) is a nonprofit, public-interest law and policy organization whose vision is a nation in which everyone is welcomed in life and protected in law. The first national pro-life organization in America, AUL has been committed to defending human life through vigorous judicial, legislative, and educational efforts at both the federal and state levels since 1971. The Wall Street Journal has profiled AUL, and PBS' Frontline program chronicled AUL's successful efforts in Mississippi.

    Media Contact
    Matthew Eppinette
    202-289-1479
    matthew.eppinette@aul.org


'/>"/>
SOURCE Americans United For Life
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New advancements in the use of adult, embryonic stem cells for tissue regeneration
2. Researchers Create Embryonic-Like Stem Cells From Human Testes
3. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
4. Public funding impacts progress of human embryonic stem cell research
5. Embryonic pathway delivers stem cell traits
6. Embryonic Pathways Induce Stem Cell Traits
7. How embryonic stem cells develop into tissue-specific cells demonstrated
8. March of Dimes awards $250,000 prize to leaders in understanding embryonic development
9. Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells
10. Embryonic Stem Cells Turned Into Three Types of Heart Cells
11. Embryonic stem cells could help to overcome immune rejection problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... It is vital for any lab to secure funding, and the best ... Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline analysis and ... a GLP (Good Laboratory Practice) fashion. , With features designed to simplify life in ...
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood associated ... appearing online in the journal Radiology. , Heart disease and brain disease exact a ... the rapidly aging population. Damage to both organs often occurs at a subclinical stage, ...
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes and ... around the nation. What do they have in common? All have been affected by ... new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. , ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Arcturus ... RNA medicines company, announced today that it entered ... develop RNA-based therapeutics for the treatment of NASH ... wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer ... "Given Takeda,s long-standing commitment to and expertise ...
(Date:12/6/2016)... , Dec. 6, 2016  Regulus Therapeutics Inc. ... leading the discovery and development of innovative medicines ... candidates at its R&D day, held in ... RGLS5040, is an anti-miR targeting microRNA-27 (miR-27) for ... RGLS4326, is an anti-miR targeting microRNA-17 (miR-17) for ...
(Date:12/6/2016)... new study released today by the Alliance for Integrity ... Pricing Program will continue to expand at an unprecedented rate ... $23 billion in total purchases at the 340B price. This ... B drug reimbursement purchases over the next five years.      ... data on total drug purchases through 340B from 2005 to ...
Breaking Medicine Technology: